Skip to main content
  • Assessment of Surgeon’s Attitude Regarding Resectabilty of Glioblastoma: A Pilot Study

    Final Number:

    Adam M. Sonabend MD; Brad E. Zacharia MD, MS; Michael Brendan Cloney BA; Christopher R Showers MS, MD (candidate); Victoria Ebiana; Mathew Nazarian; Michael B. Sisti MD; William Butler MD; Jeffrey N. Bruce MD; Guy M. McKhann

    Study Design:

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Extent of resection (EOR) of glioblastoma correlates with outcome. Factors such as resection goal, presence and resectability of residual tumor might affect EOR. Resectability of residual tumor could influence outcome independently of the amount of residual. Nevertheless, these issues remain understudied.

    Methods: Utilizing a novel software package we queried twelve academic tumor neurosurgeons to determine their surgical goal and assessment of EOR for patients with newly diagnosed glioblastoma. DICOM-formatted MRI and clinical vignettes were supplied for each patient, and answers to categorical questions were electronically obtained. Goal of surgery including gross total resection (GTR), subtotal resection (STR) or biopsy (Bx), and reasons for STR or Bx were investigated. Presence and resectability of residual tumor were also explored. The highly selected patient cohort included 2 patients who underwent Bx, 8 who underwent intentional STR, and 10 patients who underwent planned gross total resection GTR (n=20). Inter-rater reliability was assessed with Fleiss’ Kappa and intra-class correlation.

    Results: In this highly curated data set, variation among surgeons’ responses showed fair inter-rater reliability for goal of surgery (Kappa= 0.286,ICC=0.435) as well as presence and resectability of residual disease (Kappa= 0.291,ICC=0.446). STR goal predicted intraoperative decision of intentional STR documented on operative notes (T-test p<0.01), and non-resectable residual (T-test p<0.01), but not resectable residual. GTR goal correlated with the fraction of surgeons calling GTR or resectable residual on postoperative MRI (T-test p<0.01).

    Conclusions: This pilot study demonstrates the feasibility of investigating factors influencing resectability and surgical goals for glioblastoma, as well as resectability of residual disease. In this highly curated dataset, surgeon’s goals correlated well with intraoperative decisions of EOR, and EOR outcomes. Additional patients and surgeons might allow investigation EOR determinants and reproducibility of this surgery. This approach might prove useful for control/stratification of resectability-related confounders of clinical outcomes within clinical trials for glioblastoma.

    Patient Care: The approach presented constitutes a novel means to investigate determinants of the extent of resection of glioblastoma that have been neglected so far, and asses reproducibility of this neurosurgical procedure. This approach might prove useful for control/stratification of resectability-related confounders of clinical outcomes within clinical trials for glioblastoma.

    Learning Objectives: In spite of the importance of extent of resection for glioblastoma, the surgeon's decision-making process regarding the goal of surgery, the assessment of presence and resectability of residual disease remain poorly understood. We developed and tested a novel approach to investigate determinants of resectability of glioblastoma.


We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy